-- Days : -- HRS : -- MIN : -- SEC

Register Now →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Priscilla Velentgas, PhD

Articles by Priscilla Velentgas, PhD

ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

ByLinda F. Fried, MD, MPH,Natalia Petruski-Ivleva, PhD,Kerstin Folkerts, MSc,Niklas Schmedt, DrPH,Priscilla Velentgas, PhD,Csaba P. Kovesdy, MD

December 8th 2021

eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

ByLinda F. Fried, MD, MPH,Natalia Petruski-Ivleva, PhD,Kerstin Folkerts, MSc,Niklas Schmedt, DrPH,Priscilla Velentgas, PhD,Csaba P. Kovesdy, MD

December 8th 2021

Latest Updated Articles

ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease
December 8th 2021
eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease
December 8th 2021

Trending on AJMC

Lipoprotein(a): An FAQ on Awareness, Risk, and Screening Gaps

$20 Billion National Strategy Aims to Close the Women's Health Gap

GLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH

Smartwatch Study Links Midlife to Rising Nighttime Awakenings in Women

5 Novel FDA Approvals That Signal a Shift Toward Convenience-Driven Care